It is disappointing to see supplement manufacturers prioritize hype over science, as seen with the Leap Years supplement for dogs (LY-D6/2). The lack of transparency regarding the ingredients raises concerns about its effectiveness. While some components like NAD+ upregulators and senolytics show promise, without knowing the specifics of the formula, it’s hard to assess its potential benefits. Furthermore, the company’s failure to disclose crucial details reflects poorly on their credibility.
Despite publishing a study showcasing improved cognitive function in dogs, the absence of information on the supplement’s composition hinders the ability to draw meaningful conclusions. The randomized clinical trial may have shown some positive results in cognitive function, but the lack of data on physical activity and frailty leaves much to be desired. This underscores the importance of transparency and scientific rigor in the supplement industry to truly assess its impact.
Titled “The Makers of LY-D6/2 are Not Good Representatives of the Longevity Industry – Fight Aging!” the article sheds light on the questionable practices of supplement manufacturers who prioritize marketing hype over scientific evidence. Highlighting the importance of transparency and proper research in assessing the effectiveness of supplements like LY-D6/2, it emphasizes the need for clearer communication and accountability in the longevity industry.
.
